The Chosun Ilbo on MSN

FDA Speeds Up Custom Gene Therapy Approvals With Existing Data

Last May, people were thrilled to learn that a 7-month-old baby who became the first in the world to receive a personalized ...

Crispr And Intellia: Advancing In Vivo Gene Editing As 2025 Results Strengthen Investment Outlook

Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...